11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine;Dopamine serotonin antagonist-1;Dechloroclozapine;5H-Dibenzo[b,e][1,4]diazepine, 11-(4-methyl-1-piperazinyl)-;11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepineQ: What is
11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine Q: What is the CAS Number of
11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine;inhibit,Inhibitor,Muscarinic acetylcholine receptor,hM4Di,Deschloroclozapine,hM3Dq,muscarinic-based,mAChR,DREADDs;11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine;Deschloroclozapine, 10 mM in DMSO
Deschloroclozapine is a potent, high-affinity, selective, and metabolically stable agonist for muscarinic-based DREADDs (Designer Receptors Exclusively Activated by Designer Drugs); it is used to selectively and rapidly enhance neuronal activity via hM3Dq-DREADD or induce neuronal silencing via hM4Di-DREADD in vivo; it selectively induces hM3Dq-mediated metabolic activity and hM4Di-mediated behavioral deficits in animal models; it exhibits good brain penetration and biostability with negligible metabolite formation, making it suitable for in vivo studies in mice and non-human primates; it shows no significant agonistic activity against 318 wild-type GPCRs at concentrations <10 nM, ensuring high selectivity for DREADD applications.